CA Patent

CA2538419C — Use of ciclesonide for the treatment of respiratory diseases

Assigned to Covis Pharma BV · Expires 2012-07-03 · 14y expired

What this patent protects

This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.

USPTO Abstract

This invention relates to a new method of treatment of respiratory diseases, in particular the treatment of asthmatic children.

Drugs covered by this patent

Patent Metadata

Patent number
CA2538419C
Jurisdiction
CA
Classification
—
Expires
2012-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Covis Pharma BV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.